|
1
|
Petrella T, Bagot M, Willemze R, et al:
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic
neoplasms): a review. Am J Clin Pathol. 123:662–675. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adachi M, Maeda K, Takekawa M, et al: High
expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive
lymphoma. Am J Hematol. 47:278–282. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaperot L, Perrot I, Jacob MC, et al:
Leukemic plasmacytoid dendritic cells share phenotypic and
functional features with their normal counterparts. Eur J Immunol.
34:418–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boiocchi L, Lonardi S, Vermi W, Fisogni S
and Facchetti F: BDCA-2 (CD303): a highly specific marker for
normal and neoplastic plasmacytoid dendritic cells. Blood.
122:296–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burg G, Kempf W, Cozzio A, et al:
WHO/EORTC classification of cutaneous lymphomas 2005: histological
and molecular aspects. J Cutan Pathol. 32:647–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Willemze R, Jaffe ES, Burg G, et al:
WHO-EORTC classification for cutaneous lymphomas. Blood.
105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. 2. 4th edition.
IARC Press; Lyon: 2008
|
|
8
|
Dalle S, Beylot-Barry M, Bagot M, et al:
Blastic plasmacytoid dendritic cell neoplasm: is transplantation
the treatment of choice? Br J Dermatol. 162:74–79. 2010. View Article : Google Scholar
|
|
9
|
Foong HB, Chong M, Taylor EM, Carlson JA
and Petrella T: Blastic plasmacytoid dendritic cell neoplasm in an
elderly woman. Med J Malaysia. 68:161–163. 2013.PubMed/NCBI
|
|
10
|
Maio P, Fernandes C, Afonso A, Sachse F,
Cabecadas J and Cardoso J: Case for diagnosis. An Bras Dermatol.
88:131–133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garnache-Ottou F, Chaperot L, Biichle S,
et al: Expression of the myeloid-associated marker CD33 is not an
exclusive factor for leukemic plasmacytoid dendritic cells. Blood.
105:1256–1264. 2005. View Article : Google Scholar
|
|
12
|
Eichenauer D, Engert A, Diehl V, et al:
Hodgkin lymphoma: clinical manifestations, staging, and therapy.
Hematology: Basic Principles and Practice. Hoffman R, Benz EJ,
Leslie E and Silberstein LE: 6th edition. Elsevier; Saunder,
Philadelphia, PA: pp. 1138–1156. 2013
|
|
13
|
Kaushansky K, Lichtman MA, Beutler E, et
al: General Considerations of Lymphoma: Epidemiology, Etiology,
Heterogeneity, and Primary Extranodel Disease. William’s
Hematology. 8th edition. McGraw-Hill Medical; New York, NY: pp.
1497–1510. 2010
|
|
14
|
Macon WR, McCurley TL, Kurtin PJ and Dogan
A: Lymphoproliferative disorders. Wintrobe’s Clinical Hematology.
Wintrobe MM and Greer JP: 12th edition. Lippincott Williams &
Wilkins; Philadelphia, PA: pp. 2017–2311. 2009
|
|
15
|
Wiesner T, Obenauf AC, Cota C, Fried I,
Speicher MR and Cerroni L: Alterations of the cell-cycle inhibitors
p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid
dendritic cell neoplasms. J Invest Dermatol. 130:1152–1157. 2010.
View Article : Google Scholar
|
|
16
|
Bilbao EA, Chirife AM, Florio D, Gimenez
LB, Marino L and Rosso DA: Hematodermic CD4+
CD56+ neoplasm in childhood. Medicina (B Aires).
68:147–150. 2008.(In Spanish).
|
|
17
|
Marafioti T, Paterson JC, Ballabio E, et
al: Novel markers of normal and neoplastic human plasmacytoid
dendritic cells. Blood. 111:3778–3792. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dzionek A, Inagaki Y, Okawa K, et al:
Plasmacytoid dendritic cells: from specific surface markers to
specific cellular functions. Hum Immunol. 63:1133–1148. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lencastre A, Cabete J, João A, Farinha P,
Ferreira G and Lestre S: Blastic plasmacytoid dendritic cell
neoplasm. An Bras Dermatol. 88(6 Suppl 1): 158–161. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi Y and Wang E: Blastic plasmacytoid
dendritic cell neoplasm: a clinicopathologic review. Arch Pathol
Lab Med. 138:564–569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riaz W, Zhang L, Horna P and Sokol L:
Blastic plasmacytoid dendritic cell neoplasm: update on molecular
biology, diagnosis, and therapy. Cancer Control. 21:279–289.
2014.PubMed/NCBI
|
|
22
|
Julia F, Dalle S, Duru G, et al: Blastic
plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical
correlations in a series of 91 patients. Am J Surg Pathol.
38:673–680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cota C, Vale E, Viana I, et al: Cutaneous
manifestations of blastic plasmacytoid dendritic cell
neoplasm-morphologic and phenotypic variability in a series of 33
patients. Am J Surg Pathol. 34:75–87. 2010. View Article : Google Scholar
|
|
24
|
Kharfan-Dabaja MA, Lazarus HM, Nishihori
T, Mahfouz RA and Hamadani M: Diagnostic and therapeutic advances
in blastic plasmacytoid dendritic cell neoplasm: a focus on
hematopoietic cell transplantation. Biol Blood Marrow Transplant.
19:1006–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki R, Nakamura S, Suzumiya J, et al:
Blastic natural killer cell lymphoma/leukemia (CD56-positive
blastic tumor). Cancer. 104:1022–1031. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jegalian AG, Buxbaum NP, Facchetti F, et
al: Blastic plasmacytoid dendritic cell neoplasm in the pediatric
population: diagnostic features and clinical implications.
Haematologica. 95:1873–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
